Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Enrollment begins in U.S. phase III trial of ECCS-50

Aug. 7, 2015

Filgotinib meets key efficacy endpoints in phase IIb DARWIN 1 study

Aug. 3, 2015

Aurigene Discovery discloses RORgamma receptor ligands

July 29, 2015

FDA approves Dysport for upper limb spasticity

July 17, 2015

Tunable BTK inhibitors from Principia Biopharma show promise for autoimmune diseases

July 17, 2015

BTK inhibitors described in Merck & Co. patent

July 16, 2015

Seattle Genetics begins Adcetris trial in systemic lupus erythematosus

July 10, 2015

Anika Therapeutics reports data from follow-up study of Cingal

July 10, 2015

Novel BTK inhibitor shows potential for the treatment of RA

July 10, 2015

Nintedanib shows potent antifibrotic effects in preclinical models of SSc

July 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...